Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

The Romans created a remarkably organized and well-structured society. A big part of that was writing; they wrote often, and ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis.

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

A University of Warwick epigraphy expert has collaborated with Google DeepMind to evaluate "Aeneas," an AI model that ...

Prescription drugs designed by AI could be in clinical trials within years, DeepMind's CEO predicted. Demis Hassabis said in an interview he'd be "disappointed" if it took more than a couple of years.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. ... Murdoch says human clinical trials for Isomorphic’s AI-designed drugs are finally ...

Google DeepMind unveiled GenCast, its AI tool for weather forecasts. GenCast outperformed existing forecasting systems in trials, Google DeepMind said. Better forecasting will allow for better ...

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...